Successful correction of metabolic acidosis is difficult to achieve inchronic kidney disease Fernando Caravaca-Fontán; Rosa Díaz-Campillejo; Julián Valladares; Cristina López Arnaldo; Sergio Barroso; Enrique Luna; Francisco Caravaca;

Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment? Fernando Caravaca-Fontán; Julián Valladares; Rosa Díaz-Campillejo; Sergio Barroso; Enrique Luna; Francisco Caravaca;

Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain Patricia de Sequera; Ramón Bover; Yoana Ivanova-Markova; Alexandra Ivanova; Almudena González-Domínguez; Marta Valls; Verónica Campos;